Fetal death following labetalol administration in pre‐eclampsia
- 1 February 1992
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 71 (2) , 145-147
- https://doi.org/10.3109/00016349209007974
Abstract
Labetalol (Trandate®) 50 mg i.v. was administered to a pre-eclamptic primigravida with an asphytic fetus prior to cesarean section, in order to reduce the risk of excessive increase in blood pressure during induction of anesthesia. Blood pressure fell rapidly from 170/110 to 115/85 mmHg. A dead infant was born. Oral labetalol is arguably a suitable remedy for pre-eclampsia, but if i.v. administration is necessary, an initial dose of 5–10 mg is recommended.Keywords
This publication has 9 references indexed in Scilit:
- The fetal outcome in a randomized double‐blind controlled trial of labetalol versus placebo in pregnancy‐induced hypertensionBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- The use of labetalol for attenuation of the hypertensive response to endotracheal incubation in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1988
- The effect of maternal labetalol on the newborn infantBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Maternal Beta‐Adreneceptor Blockade Reduces Fetal Tolerance to Asphyxia: A study in pregnant sheepActa Obstetricia et Gynecologica Scandinavica, 1984
- Labetalol for the Treatment of Hypertension in Pregnancy: Pharmakokinetics and effects on the uteroplacental blood flowActa Obstetricia et Gynecologica Scandinavica, 1984
- Labetalol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses and Adverse EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
- Uteroplacental Blood Flow in Pre-Eclampsia Measurements with Indium-113M and a Computer-Linked Gamma CameraClinical and Experimental Hypertension. Part B: Hypertension in Pregnancy, 1982
- The electrophysiological effects of intravenous Labetalol in manEuropean Journal of Clinical Pharmacology, 1981